|
[1] CRAWFORD JM,BURT AD.Mac Sween’s pathology of the liver(six edition)[M].Churchill Livingstone Elsevier(London),2012:49-61.
|
|
[2] CAMPBELL MS,REDDY KR.Review article:the evolving role of liver biopsy[J].Aliment Pharmacol Ther,2004,20(3):249-259.
|
|
[3] World Health Organization.Prevention&control of viral hepatitis infection:framework for global action[R/OL].(2012-03-10).http://www.who.int/entity/hepatitis/publications/Framework/en.
|
|
[4] World Health Organization.Global policy report on the prevention and control of viral hepatitis in WHO member[R/OL].(2013-03-09).http://www.who.int/entity/hepatitis/publications/global_report/en.
|
|
[5] World Health Organization.Schistosomiasis[R/OL].2015.http://www.who.int/entity/mediacentre/factsheets/fs115/en.
|
|
[6] World Health Organization.Echinococcosis[R/OL].2015.http://www.who.int/entity/echinococcosis/en.
|
|
[7]MURALI AR,KOTWAL V,CHAWLA S.Chronic hepatitis E:a brief review[J].World J Hepatol,2015,7(19):2194-2201.
|
|
[8]SHERMAN KE,THOMAS D,CHUNG RT.Human immunodeficiency virus and liver disease forum 2012[J].Hepatology,2014,59(1):10.
|
|
[9] WANG F,FLANAGAN J,SU N,et al.RNAscope:A novel in Situ RNA analysis platform for formalin-fixed,paraffin-embedded tissues[J].J Mol Diagn,2012,14(1):22-29.
|
|
[10] RANDHAWA PS,JAFFE R,FARUKI H,et al.Detection of cytomegalovirus in formalin-fixed paraffin-embedded donor,native and allograft liver tissue using a multiplex polymerase chain reaction-liquid hybridization assay[J].Mod Pathol,1994,7(1):125-128.
|
|
[11]SONG LG,WU ZD.Pathology and pathogenesis of liver fibrosis induced by schistosoma japonicum[J].Chin J Schistosomiasis Control,2015,27(2):213-216,220.(in Chinese)宋兰桂,吴忠道.日本血吸虫病肝纤维化的病理学及发病机制研究进展[J].中国血吸虫病防治杂志,2015,27(2):213-216,220.
|
|
[12] ZIMMERMAN HJ.Hepatotoxicity:the adverse effects of drug and other chemicals on the liver[M].2nd ed.Philadelphia,PA:Lippincott,Williams&Wilkins,1999.
|
|
[13]KLEINER DE.The pathology of drug-induced liver injury[J].Semin Liver Dis,2009,29(4):364-372.
|
|
[14] FISHER K,VUPPALANCHI R,SAXENA R.Drug-Induced liver injury[J].Arch Pathol Lab Med,2015,139(7):876-887.
|
|
[15] DUGUM M,MCCULLOUGH A.Diagnosis and management of alcoholic liver disease[J].J Clin Transl Hepatol,2015,3(2):109-116.
|
|
[16]NEUMAN MG,FRENCH SW,FRENCH BA,et al.Alcoholic and non-alcoholic steatohepatitis[J].Exp Mol Pathol,2014,97(3):492-510.
|
|
[17]YEH MM,BRUNT EM.Pathological features of fatty liver disease[J].Gastroenterology,2014,147(4):754-764.
|
|
[18] RINELLA ME.Nonalcoholic fatty liver disease:a systematic review[J].JAMA,2015,313(22):2263-2273.
|
|
[19]ANGULO P,KLEINER DE,DAM-LARSEN S,et al.Liver fibrosis,but no other histologic features,is associated with long-term outcomes of patients with nonalcoholic fatty liver disease[J].Gastroenterology,2015,149(2):389-397.
|
|
[20]ZHOU GD,ZHAO JM,DING XH,et al.Pathological study of 130cases of nonalcoholic fatty liver disease based on NASH-CRN system[J].Med J Chin PLA,2007,32(2):96-99.(in Chinese)周光德,赵景民,丁效蕙,等.基于NASH-CRN方案的130例非酒精性脂肪性肝病病理研究[J].解放军医学杂志,2007,32(2):96-99.
|
|
[21]FRENCH SW,NASH J,SHITABATA P,et al.Pathology of alcoholic liver disease.VA Cooperative Study Group 119[J].Semin Liver Dis,1993,13(2):154-169.
|
|
[22]CARBONE M,NEUBERGER JM.Autoimmune liver disease,autoimmunity and liver transplantation[J].J Hepatol,2014,60(1):210-223.
|
|
[23]HENEGHAN MA,YEOMAN AD,VERMA S,et al.Autoimmune hepatitis[J].Lancet,2013,382(9902):1433-1444.
|
|
[24]GATSELIS NK,ZACHOU K,KOUKOULIS GK,et al.Autoimmune hepatitis,one disease with many faces:Etiopathogenetic,clinico-laboratory and histological characteristics[J].World JGastroenterol,2015,21(1):60-83.
|
|
[25]ZACHOU K,MURATORI P,KOUKOULIS GK,et al.Autoimmune hepatitis-current management and challenges[J].Aliment Pharmacol Ther,2013,38(8):887-913.
|
|
[26]BOWLUS CL,GERSHWIN ME.The diagnosis of primary biliary cirrhosis[J].Autoimmun Rev,2014,13(4-5):441-444.
|
|
[27]ZHOU GD,ZHAO JM,WANG SS,et al.Clinical and pathological analysis on characteristics of primary biliary cirrhosis[J].Chin J Hepatol,2003,11(8):483-486.(in Chinese)周光德,赵景民,王松山,等.原发性胆汁性肝硬化临床病理分析[J].中华肝脏病杂志,2003,11(8):483-486.
|
|
[28]EATON JE,TALWALKAR JA,LAZARIDIS KN,et al.Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management[J].Gastroenterology,2013,145(3):521-536.
|
|
[29]BUNCHORNTAVAKUL C,REDDY KR.Diagnosis and management of overlap syndromes[J].Clin Liver Dis,2015,19(1):81-97.
|
|
[30]FLOREANI A,FRANCESCHET I,CAZZAGON N.Primary biliary cirrhosis:overlaps with other autoimmune disorders[J].Semin Liver Dis,2014,34(3):352-360.
|
|
[31]ZEN Y,NAKANUMA Y,PORTMANN B.Immunoglobulin G4-related sclerosing cholangitis:pathologic features and histologic mimics[J].Semin Diagn Pathol,2012,29(4):205-211.
|
|
[32]KEGLEY KM,SELLERS MA,FERBER MJ,et al.Fulminant Wilson's disease requiring liver transplantation in one monozygotic twin despite identical genetic mutation[J].Am J Transplant,2010,10(5):1325-1329.
|
|
[33]ZHOU GD,ZHAO JM,ZHANG TH,et al.Congenital hepatic fibrosis:a clinicopathologic study of 7 cases[J].Chin J Diagn Pathol,2002,9(4):216-217.(in Chinese)周光德,赵景民,张泰和,等.先天性肝纤维化7例临床病理分析[J].诊断病理学杂志,2002,9(4):216-217.
|
|
[34]ZHOU GD,ZHAO JM,SUN YL,et al.Comparative study of liver fibrosis in several kinds of inherited metabolic liver disorders[J].Infect Dis Info,2008,21(5):284-286.(in Chinese)周光德,赵景民,孙艳玲,等.几种重要遗传代谢性肝病肝纤维化的比较研究[J].传染病信息,2008,21(5):284-286.
|
|
[35]SALGIA RJ,BROWN K.Diagnosis and management of hereditary hemochromatosis[J].Clin Liver Dis,2015,19(1):187-198.
|
|
[36]PLESSIER A,RAUTOU PE,VALLA DC.Management of hepatic vascular diseases[J].J Hepatol,2012,56(Suppl 1):s25-s38.
|
|
[37]FAN CQ,CRAWFORD JM.Sinusoidal obstruction syndrome(hepatic veno-occlusive disease)[J].J Clin Exp Hepatol,2014,4(4):332-346.
|
|
[38]YU CY,CHANG LC,CHEN LW,et al.Peliosis hepatis complicated by portal hypertension following renal transplantation[J].World J Gastroenterol,2014,20(9):2420-2425.
|
DownLoad: